Theralase Technologies Inc. (TLTFF)
OTCMKTS · Delayed Price · Currency is USD
0.2200
-0.0100 (-4.35%)
Feb 12, 2026, 3:11 PM EST
Theralase Technologies Market Cap
Theralase Technologies has a market cap or net worth of $58.5 million as of February 12, 2026. Its market cap has increased by 25.43% in one year.
Market Cap
58.50M
Enterprise Value
58.68M
Revenue
718.66K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.22
Market Cap Chart
Since April 2, 1996, Theralase Technologies's market cap has increased from 6.14M to 58.50M, an increase of 852.51%. That is a compound annual growth rate of 7.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 58.50M | 83.51% |
| Dec 31, 2025 | 31.88M | -30.14% |
| Dec 31, 2024 | 45.64M | 50.64% |
| Dec 28, 2023 | 30.29M | -40.82% |
| Dec 30, 2022 | 51.19M | -15.43% |
| Dec 31, 2021 | 60.53M | 98.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OpGen | 340.99M |
| Tian'an Technology Group | 182.07M |
| Zomedica | 127.05M |
| Positron | 68.49M |
| RetinalGenix Technologies | 59.54M |
| CS Diagnostics | 55.94M |
| Guided Therapeutics | 33.69M |
| Vivos | 32.75M |